MedTrace Logo

Use of an Antiemetic to Shorten the Length of Labor in Nulliparous Women

NCT01937234 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2017-03-10

No results posted yet for this study

Summary

Reducing the length of labor is a highly desirable goal of intrapartum care, both from a perspective of maternal and fetal well-being , and for the providers of the birth services. Avoiding a long , protracted labor entails shorter exposure to pain anxiety and stress and would translate into a major improvement in maternal satisfaction with the child birth experience.

The purpose of this study is to determine the effectiveness of metoclopramide for reducing the duration of spontaneous labor among nulliparous women managed according to a standard intrapartum protocol.

Conditions

  • Prolonged First Stage of Labor

Interventions

DRUG

Metoclopramide

Intravenous injection of 10mg metoclopramide, at enrollment, then every 2 hours. Maximum of 3 doses.

DRUG

Placebo

Intravenous injection of 0.9% sodium chloride, at enrollment, then every 2 hours. Maximum of 3 doses.

Sponsors & Collaborators

  • Armed Forces Hospitals, Southern Region, Saudi Arabia

    collaborator OTHER_GOV

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Mohamed I Ellaithy, MD · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2016-07-31
Completion
2016-09-30

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01937234 on ClinicalTrials.gov